We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+0.5%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$710M
AUM Growth
-$45.7M
Cap. Flow
-$39.7M
Cap. Flow %
-5.59%
Top 10 Hldgs %
9.53%
Holding
2,469
New
584
Increased
596
Reduced
458
Closed
638

Sector Composition

Rank Sector Weight
1 Technology 11.11%
2 Energy 9.76%
3 Consumer Discretionary 8.51%
4 Industrials 8.43%
5 Healthcare 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCG
376
DELISTED
CAMPUS CREST COMMUNITIES INC COM STK (MD)
CCG
$480K 0.07%
+75,000
New +$609K
ESV
377
DELISTED
Ensco Rowan plc
ESV
$480K 0.07%
2,902
+819
+39% +$162K
SAFM
378
DELISTED
Sanderson Farms Inc
SAFM
$477K 0.07%
5,427
+2,127
+64% +$201K
WPZ
379
DELISTED
WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT
WPZ
$477K 0.07%
9,554
+6,900
+260% +$343K
SM icon
380
SM Energy
SM
$6.88B
$476K 0.07%
6,099
+1,099
+22% +$89.7K
MS icon
381
Morgan Stanley
MS
$336B
$475K 0.07%
13,750
-39,050
-74% -$1.3M
NXPI icon
382
NXP Semiconductors
NXPI
$58.4B
$475K 0.07%
6,942
-137
-2% -$9.11K
CTB
383
PUT
DELISTED
Cooper Tire & Rubber Co.
CTB
$474K 0.07%
+16,500
New +$492K
PCP
384
DELISTED
PRECISION CASTPARTS CORP
PCP
$474K 0.07%
2,000
-157
-7% -$38.1K
MOVE
385
DELISTED
MOVE INC COM STK NEW (DE)
MOVE
$474K 0.07%
+22,607
New +$340K
THI
386
DELISTED
TIM HORTONS INC COM, CANADA
THI
$473K 0.07%
+6,000
New +$400K
TMO icon
387
Thermo Fisher Scientific
TMO
$214B
$471K 0.07%
3,870
PPC icon
388
Pilgrim's Pride
PPC
$6.56B
$466K 0.07%
15,250
+3,450
+29% +$104K
SABR icon
389
Sabre
SABR
$886M
$466K 0.07%
26,000
-19,000
-42% -$358K
AMGN icon
390
Amgen
AMGN
$219B
$461K 0.06%
3,279
+735
+29% +$96K
WGO icon
391
Winnebago Industries
WGO
$885M
$459K 0.06%
21,100
+15,000
+246% +$367K
BWXT icon
392
BWX Technologies
BWXT
$15.3B
$457K 0.06%
23,067
+15,711
+214% +$339K
SRCI
393
DELISTED
SRC Energy Inc
SRCI
$457K 0.06%
37,500
-112,500
-75% -$1.4M
WFM
394
PUT
DELISTED
Whole Foods Market Inc
WFM
$457K 0.06%
12,000
+7,000
+140% +$267K
ATI icon
395
ATI
ATI
$30.5B
$456K 0.06%
+12,300
New +$517K
SRPT icon
396
CALL
Sarepta Therapeutics
SRPT
$1.77B
$456K 0.06%
21,600
+8,100
+60% +$183K
AMWD
397
DELISTED
American Woodmark
AMWD
$454K 0.06%
12,317
+8,817
+252% +$304K
ARLP icon
398
PUT
Alliance Resource Partners
ARLP
$3.26B
$454K 0.06%
+10,600
New +$506K
CALL
399
DELISTED
magicJack VocalTec Ltd
CALL
$451K 0.06%
45,804
-900
-2% -$11.4K
MON
400
DELISTED
Monsanto Co
MON
$450K 0.06%
+4,000
New +$468K

Similar funds

Prelude Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Prelude Capital Management held 2,469 positions worth $710M, down 6% from $756M the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Prelude Capital Management withdrew a net $39.7M in Q3 2014, closing 638 positions and reducing 458 holdings. Its most notable exit was FOREST LABORATORIES INC, an estimated $5.64M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.1% a quarter earlier, followed by Energy and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in CONCUR TECHNOLOGIES INC worth $6.4M.

  • Prelude Capital Management's largest Q3 2014 buy was CONCUR TECHNOLOGIES INC: 50,447 shares worth $6.4M.
  • Prelude Capital Management added most to COVIDIEN PLC COM SHS NEW (IRELAND) in Q3 2014, an estimated $6.42M increase.
  • Prelude Capital Management's biggest Q3 2014 reduction was Liberty Interactive Corporation Series A Liberty Ventures, cutting an estimated $4.48M.
  • Prelude Capital Management fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $5.64M.
  • Prelude Capital Management's ten largest holdings make up 9.5% of its $710M portfolio in Q3 2014.
  • Prelude Capital Management opened 584 new positions and closed 638 in Q3 2014.
  • Prelude Capital Management's portfolio value fell 6% quarter-over-quarter to $710M.

Based on Prelude Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.